130 related articles for article (PubMed ID: 9477135)
1. Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.
Knauf WU; Langenmayer I; Ehlers B; Mohr B; Adorf D; Nerl CH; Hallek M; Zwingers TH; Emmerich B; Thiel E
Leuk Lymphoma; 1997 Nov; 27(5-6):523-32. PubMed ID: 9477135
[TBL] [Abstract][Full Text] [Related]
2. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
[TBL] [Abstract][Full Text] [Related]
5. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia.
Molica S; Levato D; Cascavilla N; Levato L; Musto P
Eur J Haematol; 1999 Feb; 62(2):117-22. PubMed ID: 10052715
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
7. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
[TBL] [Abstract][Full Text] [Related]
8. The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia.
Schwarzmeier JD; Shehata M; Hilgarth M; Marschitz I; Louda N; Hubmann R; Greil R
Leuk Lymphoma; 2002 Mar; 43(3):549-54. PubMed ID: 12002758
[TBL] [Abstract][Full Text] [Related]
9. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.
Hallek M; Langenmayer I; Nerl C; Knauf W; Dietzfelbinger H; Adorf D; Ostwald M; Busch R; Kuhn-Hallek I; Thiel E; Emmerich B
Blood; 1999 Mar; 93(5):1732-7. PubMed ID: 10029603
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia.
Callea V; Morabito F; Luise F; Piromalli A; Filangeri M; Stelitano C; Iacopino P; Nobile F; Brugiatelli M
Haematologica; 1996; 81(4):310-5. PubMed ID: 8870374
[TBL] [Abstract][Full Text] [Related]
12. [Evolution of chronic lymphocytic leukemia: predictive value of immunophenotype, soluble CD23 and morphology].
Sarmientó MA; Palacios MF; Scolnik MP; Ramírez FR; Stanganelli C; Cabrera J; Chena CP; Arrossagaray G; Slavutsky IR; Bengió RM
Medicina (B Aires); 2002; 62(4):305-12. PubMed ID: 12325485
[TBL] [Abstract][Full Text] [Related]
13. Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients.
Meuleman N; Stamatopoulos B; Dejeneffe M; El Housni H; Lagneaux L; Bron D
Leukemia; 2008 Oct; 22(10):1882-90. PubMed ID: 18633433
[TBL] [Abstract][Full Text] [Related]
14. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of the soluble low affinity receptor for IgE and soluble interleukin-2 receptor in childhood, and their relation to age, gender, atopy and allergic disease.
Miller AL; Stern DA; Martinez FD; Wright AL; Taussig LM; Halonen M
Pediatr Allergy Immunol; 1996 May; 7(2):68-74. PubMed ID: 8902856
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
Jewell AP; Worman CP; Giles FJ; Goldstone AH
Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
[TBL] [Abstract][Full Text] [Related]
17. Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23.
Kaaks R; Sookthai D; Łuczyńska A; Oakes CC; Becker S; Johnson T; Johansson A; Melin B; Sjöberg K; Trichopoulos D; Trichopoulou A; Lagiou P; Mattiello A; Tumino R; Masala G; Agnoli C; Boeing H; Aleksandrova K; Brennan P; Franceschi S; Roulland S; Casabonne D; de Sanjose S; Sánchez MJ; Huerta JM; Ardanaz E; Sala N; Overvad K; Tjønneland A; Halkjær J; Weiderpass E; Bueno-de-Mesquita HB; Vermeulen R; Peeters PH; Vineis P; Kelly RS; Khaw KT; Travis RC; Key TJ; Riboli E; Nieters A
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):538-45. PubMed ID: 25542829
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Piñeyroa JA; Magnano L; Rivero A; Rivas-Delgado A; Nadeu F; Correa JG; Giné E; Villamor N; Filella X; Colomer D; López M; López-Oreja I; Costa D; Aymerich M; Beà S; López-Guillermo A; Campo E; Delgado J; Mozas P
Hematol Oncol; 2022 Oct; 40(4):588-595. PubMed ID: 35611996
[TBL] [Abstract][Full Text] [Related]
19. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23.
Brizard A; Morel F; Lecron JC; Dreyfus B; Brizard F; Barra A; Preud'homme JL
Leuk Lymphoma; 1994 Jul; 14(3-4):311-8. PubMed ID: 7950920
[TBL] [Abstract][Full Text] [Related]
20. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
